Search This Blog

Saturday, January 5, 2019

Baird Starts AVEO Pharmaceuticals (AVEO) at Outperform


Baird analyst Madhu Kumar initiates coverage on AVEO Pharmaceuticals (NASDAQ: AVEO) with a Outperform rating

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)